Neochem Bio Solutions (NEOCHEM)₹104.600.00%Specialty Chemicals
At the end of the Mar 2026 quarter, Neochem Bio Solutions' shareholders were: promoters 66.75%, FIIs 0.18%, DIIs 15.76%, public 17.31%. Promoter holding is up 0.02 percentage points from 66.73% a quarter earlier. 0.00% of promoter shares were pledged. It had 407 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2025 | Mar 2026 | |
|---|---|---|
| Promoters | 66.73% | 66.75% |
| FIIs | 2.00% | 0.18% |
| DIIs | 13.13% | 15.76% |
| Public | 18.14% | 17.31% |
| Promoter shares pledged | — | 0.00% |
| Number of shareholders | 862 | 407 |
| Holder | Category | Mar 2026 | Change (pp) |
|---|---|---|---|
| Swapnil Rameshbhai Makati | Promoter | 54.57% | New |
| Hemangini Swapnil Dathia | Promoter | 6.36% | 0.00 |
| Meenaben Rameshbhai Dathia | Promoter | 5.79% | 0.00 |
| Sanshi Fund-I | DII | 2.98% | New |
| Mavira Growth Opportunities Fund | DII | 2.93% | +1.89 |
| Finavenue Capital Trust - Finavenue Growth Fund | DII | 2.65% | +1.46 |
| Sheetal Sagar Builders & Developers Private Limited | Public | 2.20% | New |
| Invicta Continuum Fund I | DII | 1.94% | +0.06 |
| Venturex Fund I | DII | 1.79% | +0.49 |
| Dinesh Chopra | Public | 1.54% | 0.00 |
| Aarth Aif Growth Fund | DII | 1.36% | New |
| Rikhav Securities Limited | Public | 1.32% | −0.05 |
| Dathia Swapnil Rameshbhai | Promoter | Exited | — |
| 0 | DII | Exited | — |
| Venture Capital Funds | DII | Exited | — |
Promoters held 66.75% of Neochem Bio Solutions at the end of the Mar 2026 quarter.
In the Mar 2026 quarter, foreign institutional investors (FIIs) held 0.18% (down 1.82 percentage points from 2.00% a quarter earlier) and domestic institutions (DIIs) held 15.76% (up 2.63 percentage points from 13.13% a quarter earlier).
No. The Mar 2026 filing shows no pledged promoter shares.
Neochem Bio Solutions had 407 shareholders at the end of the Mar 2026 quarter.
Sanshi Fund-I (DII) held 2.98% at the end of the Mar 2026 quarter, the largest named holding outside the promoter group.